Oral PrimeC for ALS significantly reduced toxic TDP-43 protein levels in a Phase 2b trial. PrimeC also slowed functional decline and extended survival by about 15 months. The treatment was well ...
A new pancreatic cancer drug doubles survival times. And a new treatment for a rare form of ALS slows and improves some ...
A pharmaceutical company based in New Jersey that’s known for its FDA-approved treatment for ALS is set to be acquired for $2.5 billion. Tanabe Pharma America, which operates a U.S. headquarters in ...
NASHVILLE, Tenn. (WKRN) — The Vanderbilt ALS Research Center continues to work toward an Amyotrophic Lateral Sclerosis cure. The ALS Association defines ALS — also known as Lou Gehrig’s disease — as a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Coya 302 combines a low dose of IL-2 with CTLA-4 ...
With the help of artificial intelligence, a coalition of Bay Area institutions identified 18 FDA-approved drugs that could improve the lives of those suffering from amyotrophic lateral sclerosis, ...
The search for an ALS cure, which has remained a mystery to the health care community, is now being sought out with the help of artificial intelligence. AI is being used to better coordinate all the ...
Tazbentetol demonstrated significant safety and efficacy in a phase 2a study, with 82% of treated ALS patients exhibiting stable or improved rate of decline. The Food and Drug Administration (FDA) has ...
Washington, D.C. (7News) — ALS progresses rapidly, often leaving families with little time to wait for treatment options. National non-profit "I AM ALS" is on a mission to help find a cure for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results